Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glomerulonephritis, Membranous | 1 | 2021 | 86 | 0.710 |
Why?
|
Deoxycholic Acid | 2 | 2021 | 54 | 0.380 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2542 | 0.350 |
Why?
|
Administration, Oral | 5 | 2021 | 3912 | 0.310 |
Why?
|
Biological Availability | 3 | 2021 | 397 | 0.280 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 13691 | 0.200 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2021 | 277 | 0.190 |
Why?
|
Nepal | 1 | 2021 | 295 | 0.180 |
Why?
|
Drug Compounding | 1 | 2019 | 241 | 0.160 |
Why?
|
Drug Carriers | 1 | 2021 | 690 | 0.150 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16674 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 3 | 2021 | 8300 | 0.130 |
Why?
|
Caco-2 Cells | 3 | 2020 | 388 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3547 | 0.120 |
Why?
|
Neoplasms | 1 | 2021 | 21675 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.100 |
Why?
|
Intestines | 1 | 2019 | 1923 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10940 | 0.080 |
Why?
|
Immunotherapy | 1 | 2021 | 4437 | 0.070 |
Why?
|
Mice | 3 | 2021 | 81154 | 0.070 |
Why?
|
Rats | 1 | 2021 | 24250 | 0.060 |
Why?
|
Biological Transport | 2 | 2020 | 2119 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21824 | 0.060 |
Why?
|
Animals | 5 | 2021 | 168660 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6380 | 0.040 |
Why?
|
Chenodeoxycholic Acid | 1 | 2019 | 34 | 0.040 |
Why?
|
Pharmaceutical Vehicles | 1 | 2018 | 59 | 0.040 |
Why?
|
Ions | 1 | 2019 | 265 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 738 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 53250 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2018 | 368 | 0.030 |
Why?
|
Lysine | 1 | 2019 | 1007 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2021 | 63042 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13112 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2019 | 10477 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 77410 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3680 | 0.020 |
Why?
|
Humans | 5 | 2021 | 743811 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 2638 | 0.020 |
Why?
|
Adult | 1 | 2021 | 213889 | 0.020 |
Why?
|
Male | 2 | 2021 | 349776 | 0.020 |
Why?
|
Female | 1 | 2021 | 380020 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9718 | 0.010 |
Why?
|
Concepts
(44)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_